The BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, published by the ASSOC BRAS DIVULG CIENTIFICA, serves as a vital platform for the dissemination of cutting-edge research in the fields of medicine and biological sciences. With an ISSN of 0100-879X and E-ISSN 1414-431X, this Open Access journal has been championing free access to vital scientific knowledge since 1997. It is indexed in Scopus with notable rankings across various disciplines, including a rank of #131 in General Medicine (79th percentile) and #20 in Pharmacology, Toxicology, and Pharmaceutics (75th percentile). Covering a broad scope of topics, the journal primarily focuses on areas such as biochemistry, biophysics, immunology, neuroscience, and physiology, with a commendable categorization of Q2 and Q3 quartiles for several relevant fields in 2023. Through its commitment to high-quality research and robust peer review processes, the journal not only consolidates its reputation within the academic community but also significantly contributes to the enhancement of scientific knowledge and innovation in Brazil and beyond. Researchers, professionals, and students will find an invaluable resource in this journal, which is pivotal for those looking to stay abreast of the latest developments in medical and biological research.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, published by Elsevier, is a pivotal journal in the fields of Molecular Biology and Molecular Medicine, recognized for its high impact factor and robust ranking within Scopus categories, holding prestigious quartiles in Q1 for both disciplines as of 2023. With ISSN 0925-4439 and E-ISSN 1879-260X, this journal fosters cutting-edge research from 1990 to 2025, addressing the critical molecular mechanisms underlying human diseases. Its wide-ranging scope includes original research articles, reviews, and advanced theoretical insights, serving as an essential resource for researchers, clinicians, and students alike. The journal is based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, and while it does not currently offer an open-access option, it continues to maintain a strong presence in the scientific community, enhancing our understanding of molecular processes in health and disease.

BMC Biology, a prominent open access journal published by BMC since 2003, offers a dynamic platform for the dissemination of research in the fields of biology, biochemistry, and biotechnology. Based in the United Kingdom, this journal showcases high-impact studies that cover a broad range of topics including cell biology, developmental biology, ecology, and structural biology, reflecting its commitment to advancing knowledge in the life sciences. With an impressive record of Q1 rankings across multiple categories in 2023, including Agricultural and Biological Sciences and Biochemistry, Genetics and Molecular Biology, BMC Biology stands out as a leader in these disciplines. Researchers will find a robust forum for innovative and high-quality research due to its substantial Scopus rankings, which place it within the top 10% of its field. The journal's open access policy facilitates widespread dissemination, ensuring that critical biological research is accessible to a diverse global audience. Whether you are a researcher, student, or professional in the biological sciences, BMC Biology is essential for staying informed about the latest advancements and developments in this ever-evolving field.

MOLECULAR BIOLOGY OF THE CELL is a prestigious journal published by the American Society for Cell Biology, focusing on the latest advancements in cell biology and molecular biology. Established in 1990, this journal serves as a vital forum for disseminating innovative research, methodologies, and insights that drive the understanding of cellular processes and their implications in health and disease. With a noteworthy impact factor and recognition within the top quartiles for both Cell Biology and Molecular Biology, it ranks prominently among its peers, with Scopus rankings reflecting its significance in the scientific community. Although the journal does not follow an open access model, it provides essential access options for both institutional and personal subscriptions. Researchers, professionals, and students seeking to expand their knowledge and collaborate on groundbreaking findings will find MOLECULAR BIOLOGY OF THE CELL an invaluable resource in the field.

eLife is a premier open-access journal that stands at the forefront of biological and medical research, published by eLIFE SCIENCES PUBL LTD in the United Kingdom. Since its inception in 2012, the journal has made significant strides in disseminating high-quality research across various key disciplines, including Biochemistry, Genetics and Molecular Biology, Immunology and Microbiology, and Neuroscience, maintaining a prestigious Q1 quartile ranking in all these fields as of 2023. With an impressive Scopus ranking placing it among the top-tier journals—12th in General Neuroscience, 24th in General Biochemistry, and 8th in General Immunology—eLife is recognized for its impact and influence in shaping research narratives. As an open-access journal, eLife facilitates global access to groundbreaking scientific discoveries, fostering collaboration and innovation among researchers, professionals, and students alike. With a commitment to rigorous peer review and publication excellence, eLife is not just a journal; it is a vital platform contributing to the advancement of life sciences.

Laboratory Animal Research is a prominent academic journal dedicated to advancing the field of laboratory animal science, providing a platform for researchers, professionals, and students focused on biochemistry, genetics, and molecular biology. Published by SPRINGERNATURE, this journal is recognized for its rigorous peer-review process and commitment to high-quality research, achieving a notable Q2 ranking in the Biochemistry, Genetics and Molecular Biology category as of 2023. Since becoming an Open Access journal in 2015, Laboratory Animal Research has fostered greater accessibility and dissemination of research findings, encouraging collaboration and innovation within the scientific community. With its ISSN 1738-6055 and E-ISSN 2233-7660, the journal is based in the United Kingdom and resides at CAMPUS, 4 Crinan St, London, N1 9XW, England. It is an essential resource for anyone involved in laboratory animal research and strives to enhance the welfare and scientific use of animals in research settings.

NATURE METHODS, published by NATURE PORTFOLIO, is a prestigious journal at the forefront of publishing influential research in the disciplines of Biochemistry, Biotechnology, Cell Biology, and Molecular Biology. With a high impact factor and its exemplary Q1 rankings across various categories in 2023, this journal epitomizes excellence, providing a vital platform for researchers and professionals to disseminate groundbreaking methodologies and innovative techniques that drive scientific advancement. Established in 2004 and continuing through to 2024, NATURE METHODS encompasses a diverse array of research articles, reviews, and commentary, making it an essential resource for anyone involved in the biological sciences. While the journal is not currently open access, its contributions are invaluable, offering insights that not only elevate academic discourse but also enhance experimental practice and technological application. Its influence and rigorous peer review process ensure it remains a cornerstone in the rapidly evolving fields of biochemistry and molecular biology.

EXPERIMENTAL AND MOLECULAR MEDICINE, published by SpringerNature, is a premier open-access journal that has been at the forefront of biomedical research since its establishment in 1996. With a focus on innovative studies in biochemistry, molecular biology, and clinical biochemistry, the journal has consistently maintained a distinguished position within the top quartile (Q1) across multiple categories, underscoring its significant impact in these fields. The journal offers researchers and practitioners a platform for high-quality, peer-reviewed articles that advance our understanding of molecular mechanisms underlying health and disease. As a crucial resource for scholars seeking to explore cutting-edge research and practical advancements, its inclusion in relevant databases such as Scopus reflects an exceptional ranking with notable percentiles—placing it among the best in biomedical sciences. With a commitment to open access, EXPERIMENTAL AND MOLECULAR MEDICINE ensures that findings are readily available to the global academic community, facilitating collaboration and innovation in molecular medicine.

Advanced Biology, published by WILEY-V C H VERLAG GMBH, serves as a premier platform where innovative research and scientific breakthroughs in the fields of biochemistry, genetics, and molecular biology converge. Established in 2021, this journal has rapidly ascended to prominence, securing Q1 rankings in its primary categories, including general biochemistry and biomedical engineering, and a solid Q2 ranking in biomaterials. With an ISSN of 2701-0198 and an emphasis on open access, Advanced Biology ensures that rigorous peer-reviewed research is accessible to a global audience, enhancing visibility and fostering collaboration among researchers, professionals, and students alike. By 2024, it aims to continually elevate scientific understanding and innovation, catering to the growing interdisciplinary nature of these critical fields. With Scopus rankings placing it amongst the top quartiles in its disciplines, Advanced Biology is poised to make significant contributions to the future of life sciences.

BIOLOGY OF THE CELL is a prominent academic journal published by Wiley, dedicated to advancing the field of cellular biology through the dissemination of innovative research and insights. With its ISSN (0248-4900) and E-ISSN (1768-322X), this journal has been a vital resource since its inception in 1981 and is set to continue its scholarly contributions until 2024. Positioned within the Q3 quartile in Cell Biology and Q2 in Medicine (miscellaneous) as of 2023, BIOLOGY OF THE CELL is recognized for its rigorous peer-review process and its commitment to high-quality publication in critical areas such as biochemistry, genetics, and molecular biology. Although the journal does not currently offer open access options, it remains accessible through the Wiley platform, ensuring that researchers, professionals, and students can benefit from its rich repository of knowledge. By linking fundamental cellular processes with broader medical implications, this journal serves as a critical platform for fostering dialogue and innovation in cellular research, making it an essential read for anyone engaged in the life sciences.